Gene · 11167
Papers1,795
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,795
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exercise, Exerkines, and Sarcopenia. | Diabetes Metab J | 2026 | 41531287 | PubTator, text mining | PubMed |
| Targeting brain insulin signaling to combat metabolic disorders. | Neuron | 2026 | 41506241 | PubTator, text mining | PubMed |
| Activating the Osteoblastic USP26 Pathway Alleviates Multi-Organ Fibrosis by Decreasing Insulin Resistance. | Adv Sci (Weinh) | 2026 | 41417635 | PubTator, text mining | PubMed |
| FSTL1 Orchestrates Metabolic-Epigenetic Crosstalk: Glycolysis-Dependent H3K18 Lactylation Drives Cartilage Fibrosis in Osteoarthritis. | Adv Sci (Weinh) | 2026 | 41293926 | PubTator, text mining | PubMed |
Corrigendum to "FSTL1 promotes osteoclast differentiation and Accelerates periprosthetic osteolysis via PP2A Cα-Mediated activation of the JNK signaling pathway" [Biochem. Pharmacol. 242 (2025) 117450]. | Biochem Pharmacol | 2026 | 41264976 | PubTator, text mining | PubMed |
The relationship between FSTL-1 (follistatin-related protein 1), FAM19A5 (family with sequence similarity 19, member A5) and CTRP-6 (C1q/TNF-related protein 6) levels and metabolic parameters in overweight children. | J Pediatr Endocrinol Metab | 2026 | 41211872 | PubTator, text mining | PubMed |
| Letter to the Editor: Beyond AUROC-Critical evaluation of FSTL-1 as a liver fibrosis biomarker. | Hepatology | 2026 | 41183308 | PubTator, text mining | PubMed |
| Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non-small cell lung cancer. | Int J Cancer | 2026 | 41139840 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Based Therapies: Challenges and Enhancement Strategies. | Cell Biochem Biophys | 2026 | 41004016 | PubTator, text mining | PubMed |
| High FSTL1 expression promotes bladder cancer progression by enhancing tumor cell migration. | Clin Transl Oncol | 2026 | 40658162 | PubTator, text mining | PubMed |
| Regulation of Cancer Stem Cells in the Tumor Microenvironment. | Cancer Heterog Plast | 2025 | 41868064 | PubTator, text mining | PubMed |
| Harnessing mesenchymal stromal cells for liver disease therapy: from mechanistic discoveries to clinical breakthroughs. | Front Med (Lausanne) | 2025 | 41717346 | PubTator, text mining | PubMed |
| Impact of follistatin-like 1 on cardiac repair processes following myocardial infarction. | Front Cell Dev Biol | 2025 | 41602834 | PubTator, text mining | PubMed |
| Human molecular mechanisms of lumbar disc degeneration: A scoping review. | Spine Open | 2025 | 41585630 | PubTator, text mining | PubMed |
| Can alternatives to animal testing yield useful information regarding biological mechanisms and drug discovery? | J Orthop Translat | 2025 | 41542102 | PubTator, text mining | PubMed |
| Synolitic Graph Neural Networks of High-Dimensional Proteomic Data Enhance Early Detection of Ovarian Cancer. | Cancers (Basel) | 2025 | 41463217 | PubTator, text mining | PubMed |
| Follistatin-like 1: a novel biomarker with a potential link to obstructive sleep apnea severity and treatment efficacy. | Front Endocrinol (Lausanne) | 2025 | 41458545 | PubTator, text mining | PubMed |
| Denosumab attenuates knee osteoarthritis progression by inhibiting synovial inflammation via the RANK/TRAF6/FSTL1 signalling. | Nat Commun | 2025 | 41407913 | PubTator, text mining | PubMed |
| Significance of serum follistatin-like 1 as a potential biomarker in relation to 3-month cognitive impairment after acute intracerebral hemorrhage: A prospective observational cohort study. | Medicine (Baltimore) | 2025 | 41327667 | PubTator, text mining | PubMed |
| FSTL1 silencing protects against lipopolysaccharide-induced ferroptosis in renal tubular cells by regulating the PI3K/Akt pathway. | Peptides | 2025 | 41297179 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11167/papers?page=3